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Is there a silver lining to the Zika virus epidemic in the 
Americas?
It is hard to find anything positive to say about an 
epidemic of an emerging virus that infects pregnant 
women, targets developing fetuses’ neural progenitor 
cells, and disrupts the sequence of neural development 
to cause a devastating syndrome resulting in lifelong 
disabilities. Infants with microcephaly became the 
faces of the Zika virus epidemic in the Americas, which 
affected almost all countries in the western hemisphere 
in 2014–17. By the end of 2017, Zika virus has nearly 
disappeared from the Americas as quickly as it emerged. 
Now that the dust is settling, what have the scientific 
and public health communities learned? Is there a silver 
lining to Zika’s devastation?
The American Zika virus epidemic mobilised 
scientists throughout the region and beyond with a 
force reminiscent of the response to the emergence 
of HIV. As emerging infections do not follow the same 
pace as research funding agencies, many scientists, 
staff, and students worked without pay early in the 
epidemic. They understood the urgency of their work 
and were passionate to uncover the fundamental 
rules of Zika virus: modes of transmission, accurate 
diagnosis, spectrum of clinical manifestations, and 
methods of prevention and treatment. To uncover 
these rules, scientific teams crossed disciplines—in our 
case, a virologist, perinatologist, child psychologist, 
immunologist, and infectious disease specialist often 
shared calls across countries and time zones. These 
multidisciplinary research teams endure and will tackle 
other high burden diseases in the future.
To address the problem of diagnosis of the closely 
related Zika and dengue viruses, these teams raced to 
develop novel recombinant antigens and monoclonal 
antibodies to differentiate the two infections.1–3 Another 
major advance came in the use and adaptation of child 
development assessment tools. In many low-income 
and middle-income countries (LMICs), these assessment 
tools are not in routine use and are not widely available. 
The response to the Zika virus epidemic resulted in 
an increasing number of child behaviour specialists 
who became skilled in using these assessment tools 
for research. Not surprisingly, with all of these efforts, 
the number of Zika-related publications in PubMed 
rose from just three in all of 2013 to an average of 
177 publications per month in 2019. We now know 
the ways in which Zika virus can be transmitted, 
have improved diagnostics, better understand the 
full spectrum of clinical disease, and have made 
major advances in the development of Zika virus 
vaccine candidates. In carrying out their work, these 
collaborations between high-income countries and 
LMICs, and between LMICs, undoubtedly strengthened 
research and laboratory capacity in the region.
Similarly, the public health communities in countries 
affected by Zika virus mobilised in response to the 
epidemic. These institutions strengthened surveillance 
for birth defects and devised new approaches to 
surveillance of emerging infections in pregnant 
women.4 In most cases, these communities became 
aware that services for affected children were 
inadequate. To address the inadequate access to child 
behavioural specialists in LMICs, UNICEF and others are 
now implementing early childhood interventions to 
support the development of children, including those 
without Zika virus infection.5 The Zika virus epidemic 
added momentum to this “imperative for action and 
measurement at scale”5 for at-risk children in LMICs. 
There are also efforts to educate health-care providers 
on the evaluation of child development and to provide 
guidance about early stimulation. Many interventions 
consider the realities of the local context in LMICs and 
can be carried out by the child’s caregivers. Even simple 
interventions, when introduced early in a child’s life, 
have been shown to generate lifelong gains.6 However, 
these interventions will need to be longitudinal: delayed 
neurodevelopment, most notably in language, was 
recently reported in toddlers exposed to Zika virus 
in utero.7 An important lesson learned from the HIV 
epidemic was that affected children and families need 
a lifetime of psychosocial support and behavioural 
interventions to complement their medical care.8 For 
families affected by Zika virus, a difficult road still lies 
ahead, and we must continue to provide necessary 
support services even though the initial urgency of the 
outbreak has passed.
Whether or not we experience future Zika virus 
epidemics, we will certainly see the emergence of 
new pathogens with unanticipated consequences. 
In applying the lessons of Zika virus to the next 
epidemic, we should rapidly deploy research funding 
and prioritise ethical reviews of emerging infection 
research. We should work to continue to strengthen 
surveillance systems and be ready to integrate efforts to 
prevent transmission with maternal, reproductive, and 
paediatric health services.9 For Zika virus specifically, a 
silver lining is that we now understand its fundamental 
rules, and can confront the next epidemic armed with 
this knowledge.
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